Annual Cash & Cash Equivalents
$71.29 M
-$48.42 M-40.45%
December 31, 2023
Summary
- As of February 7, 2025, BPMC annual cash & cash equivalents is $71.29 million, with the most recent change of -$48.42 million (-40.45%) on December 31, 2023.
- During the last 3 years, BPMC annual cash & cash equivalents has fallen by -$613.35 million (-89.59%).
- BPMC annual cash & cash equivalents is now -89.59% below its all-time high of $684.64 million, reached on December 31, 2020.
Performance
BPMC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$89.36 M
+$34.59 M+63.14%
September 30, 2024
Summary
- As of February 7, 2025, BPMC quarterly cash and cash equivalents is $89.36 million, with the most recent change of +$34.59 million (+63.14%) on September 30, 2024.
- Over the past year, BPMC quarterly cash and cash equivalents has increased by +$33.38 million (+59.64%).
- BPMC quarterly cash and cash equivalents is now -87.20% below its all-time high of $697.97 million, reached on March 31, 2021.
Performance
BPMC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BPMC Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.5% | +59.6% |
| 3 y3 years | -89.6% | +18.3% |
| 5 y5 years | +4.7% | +18.3% |
BPMC Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -66.0% | at low | -69.3% | +140.2% |
| 5 y | 5-year | -89.6% | at low | -87.2% | +140.2% |
| alltime | all time | -89.6% | +3487.6% | -87.2% | +140.2% |
Blueprint Medicines Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $89.36 M(+63.1%) |
| Jun 2024 | - | $54.77 M(-51.7%) |
| Mar 2024 | - | $113.33 M(+59.0%) |
| Dec 2023 | $71.29 M(-40.5%) | $71.29 M(+27.4%) |
| Sep 2023 | - | $55.97 M(-25.9%) |
| Jun 2023 | - | $75.53 M(-55.5%) |
| Mar 2023 | - | $169.72 M(+41.8%) |
| Dec 2022 | $119.71 M(-43.0%) | $119.71 M(-58.9%) |
| Sep 2022 | - | $291.43 M(+68.1%) |
| Jun 2022 | - | $173.40 M(+366.1%) |
| Mar 2022 | - | $37.20 M(-82.3%) |
| Dec 2021 | $209.95 M(-69.3%) | $209.95 M(-62.1%) |
| Sep 2021 | - | $553.59 M(+3.6%) |
| Jun 2021 | - | $534.32 M(-23.4%) |
| Mar 2021 | - | $697.97 M(+1.9%) |
| Dec 2020 | $684.64 M(+500.9%) | $684.64 M(+21.1%) |
| Sep 2020 | - | $565.22 M(+95.8%) |
| Jun 2020 | - | $288.68 M(-23.1%) |
| Mar 2020 | - | $375.17 M(+229.3%) |
| Dec 2019 | $113.94 M | $113.94 M(+27.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $89.24 M(+8.3%) |
| Jun 2019 | - | $82.42 M(+3.8%) |
| Mar 2019 | - | $79.39 M(+16.6%) |
| Dec 2018 | $68.06 M(-83.0%) | $68.06 M(-13.4%) |
| Sep 2018 | - | $78.64 M(-33.2%) |
| Jun 2018 | - | $117.75 M(-12.7%) |
| Mar 2018 | - | $134.89 M(-66.3%) |
| Dec 2017 | $400.30 M(+668.8%) | $400.30 M(+598.3%) |
| Sep 2017 | - | $57.33 M(-37.2%) |
| Jun 2017 | - | $91.35 M(+62.1%) |
| Mar 2017 | - | $56.36 M(+8.2%) |
| Dec 2016 | $52.07 M(-68.0%) | $52.07 M(-30.0%) |
| Sep 2016 | - | $74.40 M(-32.0%) |
| Jun 2016 | - | $109.39 M(-10.6%) |
| Mar 2016 | - | $122.29 M(-24.8%) |
| Dec 2015 | $162.71 M(+244.4%) | $162.71 M(-9.5%) |
| Sep 2015 | - | $179.78 M(-7.1%) |
| Jun 2015 | - | $193.59 M(+284.9%) |
| Mar 2015 | - | $50.30 M(+6.5%) |
| Dec 2014 | $47.24 M(+2277.5%) | $47.24 M |
| Dec 2013 | $1.99 M | - |
FAQ
- What is Blueprint Medicines annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Blueprint Medicines?
- What is Blueprint Medicines annual cash & cash equivalents year-on-year change?
- What is Blueprint Medicines quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Blueprint Medicines?
- What is Blueprint Medicines quarterly cash and cash equivalents year-on-year change?
What is Blueprint Medicines annual cash & cash equivalents?
The current annual cash & cash equivalents of BPMC is $71.29 M
What is the all time high annual cash & cash equivalents for Blueprint Medicines?
Blueprint Medicines all-time high annual cash & cash equivalents is $684.64 M
What is Blueprint Medicines annual cash & cash equivalents year-on-year change?
Over the past year, BPMC annual cash & cash equivalents has changed by -$48.42 M (-40.45%)
What is Blueprint Medicines quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BPMC is $89.36 M
What is the all time high quarterly cash and cash equivalents for Blueprint Medicines?
Blueprint Medicines all-time high quarterly cash and cash equivalents is $697.97 M
What is Blueprint Medicines quarterly cash and cash equivalents year-on-year change?
Over the past year, BPMC quarterly cash and cash equivalents has changed by +$33.38 M (+59.64%)